Security
TECH · BIO-TECHNE Corp
TECHNASDAQCommon stockCurrentCIK 842023Updated Sep 24, 2026
Name history
TECHNE CORP /MN/ · through Oct 28, 2014
TECH price & chart
Loading TradingView…
NASDAQ:TECH on TradingView ↗About the company
Bio Techne Corporation (NASDAQ: TECH) is a global life sciences company headquartered in Minnesota, celebrating 50 years of empowering scientific and diagnostic communities to reach better answers. The company provides high quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer focused brands: R&D Systems™, Bio Techne Spatial™, and Bio Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical decision making. Bio Techne operates in 34 locations worldwide and employs more than 3,000 people. In fiscal year 2025, the company generated over $1.2 billion in net sales. Its more than 500,000 products are used globally by academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.
In the news
Shareholder Alert: Ademi LLP investigates whether Bio-Techne Corporation is obtaining a Fair Price for Public Shareholders ↗
Bio-Techne Declares Dividend ↗
Recent filings
Submission of Matters to a Vote of Security Holders · Regulation FD Disclosure
Items 5.07, 7.01, 9.01
DEFA14A filing
Other Events
Items 8.01
DEFA14A filing
DEFA14A filing
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 2,586,726,000Source | 2,557,868,000Source | 2,703,867,000Source | 2,638,692,000Source |
| Property, Plant and Equipment, NetUSD | 231,836,000Source | 245,719,000Source | 251,154,000Source | 226,200,000Source |
| GoodwillUSD | 975,355,000Source | 980,935,000Source | 972,663,000Source | 872,737,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 303,465,000Source | 365,599,000Source | 507,081,000Source | 534,645,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 264,712,000Source | 162,186,000Source | 151,791,000Source | 180,571,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 216,585,000Source | 206,876,000Source | 241,394,000Source | 218,468,000Source |
| Inventory, NetUSD | 195,744,000Source | 189,446,000Source | 179,731,000Source | 171,638,000Source |
| Assets, CurrentUSD | 744,401,000Source | 608,300,000Source | 617,419,000Source | 621,482,000Source |
| Operating Lease, Right-of-Use AssetUSD | 67,333,000Source | 73,399,000Source | 91,285,000Source | 98,326,000Source |
| Other Assets, NoncurrentUSD | 264,336,000Source | 273,609,000Source | 264,265,000Source | 285,302,000Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 1,561,000Source | 1,550,000Source | 1,582,000Source | 1,576,000Source |
| Retained Earnings (Accumulated Deficit)USD | 1,144,188,000Source | 1,066,049,000Source | 1,325,247,000Source | 1,309,461,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -70,580,000Source | -59,880,000Source | -78,316,000Source | -66,064,000Source |
| Stockholders' Equity Attributable to ParentUSD | 2,108,221,000Source | — | 2,068,850,000Source | 1,966,516,000Source |
| Additional Paid in Capital, Common StockUSD | 1,033,052,000Source | 911,089,000Source | 820,337,000Source | 721,543,000Source |
| Liabilities and EquityUSD | 2,586,726,000Source | 2,557,868,000Source | 2,703,867,000Source | 2,638,692,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 163,700,000Source | 175,849,000Source | 159,379,000Source | 128,509,000Source |
| Operating Lease, Liability, CurrentUSD | 14,935,000Source | 14,098,000Source | 12,920,000Source | 11,199,000Source |
| Accounts Payable, CurrentUSD | 26,699,000Source | 25,311,000Source | 37,968,000Source | 25,679,000Source |
| Operating Lease, Liability, NoncurrentUSD | 74,152,000Source | 83,960,000Source | 87,618,000Source | 93,766,000Source |
| Deferred Income Tax Liabilities, NetUSD | 19,308,000Source | 6,169,000Source | 55,863,000Source | 88,982,000Source |
| Other Liabilities, NoncurrentUSD | 21,345,000Source | 27,082,000Source | 13,157,000Source | 10,919,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 20,458,000Source | 25,663,000Source | 24,886,000Source | 14,880,000Source |
| Deferred Tax Liabilities, NetUSD | 19,308,000Source | — | 55,863,000Source | 88,982,000Source |
| Short-term InvestmentsUSD | — | — | 1,072,000Source | 23,739,000Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 181,862,000Source | 73,400,000Source | 168,105,000Source | 285,442,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 97,359,000Source | 109,903,000Source | 111,711,000Source | 107,238,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 41,365,000Source | 40,833,000Source | 38,042,000Source | 39,230,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 8,232,000Source | 18,144,000Source | 14,215,000Source | 30,167,000Source |
| Deferred Income Tax Expense (Benefit)USD | 23,679,000Source | -51,152,000Source | -40,161,000Source | -29,799,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 292,073,000Source | 287,556,000Source | 298,981,000Source | 254,393,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | 169,707,000Source | 101,184,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -18,190,000Source | -35,183,000Source | -203,030,000Source | -265,649,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 28,850,000Source | 31,006,000Source | 62,877,000Source | 38,244,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 12,141,000Source | 6,522,000Source | 21,872,000Source | 28,893,000Source |
| Payments for Repurchase of Common StockUSD | 41,675,000Source | 275,731,000Source | 80,042,000Source | 19,562,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -169,114,000Source | -253,905,000Source | -122,398,000Source | 22,616,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 49,916,000Source | 50,391,000Source | 50,419,000Source | 50,285,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | -2,457,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 102,526,000Source | 10,395,000Source | -28,780,000Source | 8,004,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 14,395,000Source | 18,955,000Source | 14,502,000Source | 8,368,000Source |
| Income Taxes Paid, NetUSD | 64,149,000Source | 74,357,000Source | 65,254,000Source | 88,428,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 40,277,000Source | 41,217,000Source |
| Amortization of Intangible AssetsUSD | 61,788,000Source | 76,043,000Source | 79,854,000Source | 77,491,000Source |
| Debt and Equity Securities, Realized Gain (Loss)USD | — | — | 300,000Source | — |
| DepreciationUSD | 36,200,000Source | 34,600,000Source | — | — |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | 887,000Source | 938,000Source | — | — |
| Gain (Loss) on InvestmentsUSD | -5,862,000Source | — | 283,000Source | 49,328,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | -3,506,000Source | — |
| GoodwillUSD | 975,355,000Source | 980,935,000Source | 972,663,000Source | 872,737,000Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | 73,350,000Source | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | 887,000Source | 938,000Source | -6,841,000Source | -1,143,000Source |
| Income Tax Expense (Benefit)USD | 58,818,000Source | 25,063,000Source | 17,584,000Source | 53,217,000Source |
| InterestExpenseNonoperatingUSD | 9,630,000Source | 8,509,000Source | 15,736,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | 73,400,000Source | 168,105,000Source | 285,263,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | 179,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 181,840,000Source | 73,363,000Source | 168,072,000Source | 285,193,000Source |
| Nonoperating Income (Expense)USD | -11,210,000Source | -3,792,000Source | -20,997,000Source | 39,715,000Source |
| Operating ExpensesUSD | 547,181,000Source | 688,017,000Source | 563,039,000Source | 470,871,000Source |
| Other Nonoperating Income (Expense)USD | -5,803,000Source | 831,000Source | -8,584,000Source | 47,520,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | 35,236,000Source |
| Proceeds from Stock Options ExercisedUSD | 80,618,000Source | 51,739,000Source | 60,935,000Source | 29,813,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | -5,862,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 1,215,039,000Source | 1,219,635,000Source | 1,159,060,000Source | 1,136,702,000Source |
| Cost of RevenueUSD | 415,968,000Source | 429,363,000Source | 389,335,000Source | 366,887,000Source |
| Selling, General and Administrative ExpenseUSD | 452,415,000Source | 588,521,000Source | 466,375,000Source | 378,378,000Source |
| Operating Income (Loss)USD | 251,890,000Source | 102,255,000Source | 206,686,000Source | 298,944,000Source |
| Other Nonoperating Income (Expense)USD | -5,803,000Source | 831,000Source | -8,584,000Source | 47,520,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 240,680,000Source | 98,463,000Source | 185,689,000Source | 338,659,000Source |
| Income Tax Expense (Benefit)USD | 58,818,000Source | 25,063,000Source | 17,584,000Source | 53,217,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | 179,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | 73,400,000Source | 168,105,000Source | 285,263,000Source |
| Earnings Per Share, BasicUSD per share | 1.17Source | 0.47Source | 1.07Source | 1.81Source |
| Earnings Per Share, DilutedUSD per share | 1.16Source | 0.46Source | 1.05Source | 1.76Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 155,963,000Source | 157,521,000Source | 157,708,000Source | 157,179,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 157,009,000Source | 159,717,000Source | 160,774,000Source | 161,855,000Source |
| Interest Expense (non-operating)USD | 9,630,000Source | 8,509,000Source | 15,736,000Source | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 61,788,000Source | 76,043,000Source | 79,854,000Source | 77,491,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | 6,980,000Source | -9,965,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 0.32Source | 0.32Source | 0.32Source | 0.32Source |
| Current Income Tax Expense (Benefit)USD | 35,139,000Source | 76,215,000Source | 57,745,000Source | 83,016,000Source |
| Debt and Equity Securities, Realized Gain (Loss)USD | — | — | 300,000Source | — |
| Gain (Loss) on InvestmentsUSD | -5,862,000Source | — | 283,000Source | 49,328,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | -3,506,000Source | — |
| Gross ProfitUSD | 799,071,000Source | 790,272,000Source | 769,725,000Source | 769,815,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 216,622,000Source | 86,814,000Source | 174,806,000Source | 288,458,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 887,000Source | 938,000Source | -6,841,000Source | -1,143,000Source |
| Interest ExpenseUSD | — | — | — | 11,215,000Source |
| Investment Income, NetUSD | 4,223,000Source | 3,886,000Source | 3,323,000Source | 3,410,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 181,840,000Source | 73,363,000Source | 168,072,000Source | 285,193,000Source |
| Nonoperating Income (Expense)USD | -11,210,000Source | -3,792,000Source | -20,997,000Source | 39,715,000Source |
| Operating ExpensesUSD | 547,181,000Source | 688,017,000Source | 563,039,000Source | 470,871,000Source |
| Reclassification from AOCI, Current Period, before Tax, Attributable to ParentUSD | — | -11,209,000Source | -13,527,000Source | — |
| Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD | 22,000Source | 37,000Source | 33,000Source | 70,000Source |
Filing attachments
ef20082601_ex99-1.htm · 8-K · 2026-09-23
Exhibit 99.1 Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany MINNEAPOLIS - September 23, 2026 - Bio-Techne Corporation (NASDAQ: TECH) (“Bio-Techne”), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt the definitive agreement under which Merck KGaA, Darmstadt, Germany proposes to acquire Bio-Techne (the “Merger Agreement”) at a Special Meeting of Shareholders held today. “W…
Read attachment ↗tech-20260812xex99d1.htm · 8-K · 2026-08-12
EX-99.1 2 tech-20260812xex99d1.htm EX-99.1 Exhibit 99.1 Bio-Techne Releases Fourth Quarter Fiscal 2026 Results Minneapolis/August 12, 2026/ Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026. Fourth Quarter FY2026 Highlights ●Fourth quarter organic revenue increased by 3% (1% reported) to $321.2 million. Full year organic and reported revenue remained flat at $1.2 billion. ●GAAP EPS increased to $0.35 from $(0.11) one y…
Read attachment ↗tech-20260812xex99d2.htm · 8-K · 2026-08-12
EX-99.2 3 tech-20260812xex99d2.htm EX-99.2 ex_330132.htm Exhibit 99.2 Bio-Techne Declares Dividend MINNEAPOLIS, August 12, 2026/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable September 4, 2026, to all common shareholders of record on August 24, 2026. Future cash dividends will be considered by the Board of Directors on a q…
Read attachment ↗ex99-1.htm · 8-K · 2026-06-25
EX-99.1 2 ex99-1.htm JOINT PRESS RELEASE, DATED JUNE 25, 2026 BIO-TECHNE CORPORATION 8-K EXHIBIT 99.1 News Release Your Contact Media Relations media@emdgroup.com Phone: +49 151 1454 9258 Investor Relations investor.relations@emdgroup.com Phone: +49 6151 72 3321 June 25, 2026 Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Le…
Read attachment ↗tech-20260506xex99d1.htm · 8-K · 2026-05-06
EX-99.1 2 tech-20260506xex99d1.htm EX-99.1 Exhibit 99.1 Bio-Techne Releases Third Quarter Fiscal 2026 Results Minneapolis/May 6, 2026/ Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2026. Third Quarter FY2026 Highlights ●Reported and organic revenue declined 2% to $311.4M, negatively impacted by prior-year GMP fast-track orders and timing of large Commercial Supply shipments ●GAAP EPS increased to $0.32 from $0.14; adjus…
Read attachment ↗tech-20260506xex99d2.htm · 8-K · 2026-05-06
EX-99.2 3 tech-20260506xex99d2.htm EX-99.2 ex_330132.htm Exhibit 99.2 Bio-Techne Declares Dividend MINNEAPOLIS, May 6, 2026/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2026. The quarterly dividend will be payable May 29, 2026, to all common shareholders of record on May 18, 2026. Future cash dividends will be considered by the Board of Directors on a quarterly ba…
Read attachment ↗